Considerable Uncertainty Exists Regarding Effects of Puberty Blockers
By Elana Gotkine HealthDay Reporter
FRIDAY, Jan. 24, 2025 -- There is considerable uncertainty regarding the effects of puberty blockers in young individuals experiencing gender dysphoria (GD), according to two reviews published online Jan. 23 in the Archives of Disease in Childhood.
Anna Miroshnychenko, from McMaster University in Hamilton, Ontario, Canada, and colleagues conducted two systematic reviews to assess and summarize the certainty of the evidence about the effects of puberty blockers in individuals experiencing GD. Studies comparing puberty blockers with no puberty blockers in individuals younger than 26 years experiencing GD were included (10 studies in the first review and 24 in the second).
In the first review, the researchers found that three comparative observational studies provided very low-certainty evidence on the outcomes of global function and depression. Seven before-after studies provided very low-certainty evidence with respect to GD, global function, depression, and bone mineral density. Similar results were seen in the second review; however, one comparative observational study noted lower odds of depression in individuals who received gender-affirming hormone therapy compared with those who did not (odds ratio, 0.7; low certainty). In addition, the results of two case-series studies noted that the proportion of individuals with cardiovascular events seven to 109 months after receiving gender-affirming hormone therapy was 40 per 1,000 (high certainty).
"There is considerable uncertainty about the effects of gender-affirming hormone therapy and we cannot exclude the possibility of benefit or harm," the authors write. "Methodologically rigorous prospective studies are needed to produce higher-certainty evidence."
Abstract/Full Text 1 (subscription or payment may be required)
Abstract/Full Text 2 (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-26 00:00
Read more
- Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome
- U.S. FDA Granted Priority Review to Dizal's Sunvozertinib New Drug Application
- Job Protections Improve Mental Health Among LGBTQ+ Workers
- Bird Flu Kills 20 Million Chickens in U.S., Driving Egg Prices Sky-High
- Job Strain Can Worsen Sleep Longterm, Data Suggests
- Stressed-Out Surgeon? That's Good News for Patients!
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions